Global burden of COPD: systematic review and meta-analysis
By R. Halbert, J. Natoli, Anacleto D Gano, E. Badamgarav, A. Buist, David M. Mannino. European Respiratory Journal, 2006
1,607 citations recorded by the source corpus.
Subfields: Pulmonary and Respiratory Medicine, Sociology and Political Science
View Paper: https://www.semanticscholar.org/paper/a2290c9339c41562af0b4fc222acbaa26cada09c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
- P. Barnes
- David M. Mannino
- R. Rodríguez-Roisín
- C. Jenkins
- Sonia Buist
- Jan Zieliński
- Yoshinosuke Fukuchi
- S. Hurd
In Sociology and Political Science
- R. Rodríguez-Roisín
- P. Barnes
- Michael A. McDaniel
- Michael T. Brannick
- S. Hurd
- A. Anzueto
- P. Calverley
- Sven Kepes
Citations in the corpus
- Critical review: vegetables and fruit in the prevention of chronic diseases (2012, background): “6 %, and for adults aged C40 years, the prevalence is 9 %-10 % [128].”
- Identifying Individuals with Physcian Diagnosed COPD in Health Administrative Databases (2009, background): “Previous population work evaluating the burden of COPD has been based on national population based cross-sectional surveys and cohort studies in specific populations (1).”
- Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data (2015, background): “, when there are multiple studies within a country and the aim is to provide a single summary estimate for that country), meta-analysis may well be appropriate.(16) In these cases, ‘meta-analysis involving a standardized recalculation of rates from many previous studies should generate a distributio”
- Ageing and the epidemiology of multimorbidity (2014, background): “The estimated prevalence of COPD in 28 countries among adults aged >40 years is 9–10% [14].”
- Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis (2020, neutral): “6% (95% CI 12�0–15�2) and the global prevalence of COPD (9–10%) [33, 34].”
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, methodology): “d The goals of COPD assessment are to determine: (1) the impact of the disease on the patient’s health status, (2) the severity of airflow limitation, and (3) the risk of future exacerbations, in order to guide therapy.”
- Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. (2007, methodology): “The prevalence of COPD displays a wide range of variation due to differences in epidemiologic methodology, proportions of age and sex, response rate, and diagnostic criteria of COPD used, as described by Haibert (4, 30) and others (28, 29).”
- Meta-analytic Reviews in the Organizational Sciences: Two Meta-analytic Schools on the Way to MARS (the Meta-analytic Reporting Standards) (2013, methodology): “Also, more explicit descriptions of how studies in non-English languages and non-published samples have been treated should become common practice (see, e.g., Halbert et al. 2006; Kuncel et al. 2001; Terrizzi et al. 2013).”